Brief: Neurovive Pharmaceutical Q4 Pre-Tax Loss Widens To SEK 20 Million

Abliva AB

28/02/2019 07:37

Feb 28 (Reuters) - NeuroVive Pharmaceutical AB  NVP.ST :
    * Q4 NET SALES SEK 5,000 VERSUS SEK 0 YEAR AGO
    * Q4 PRE-TAX LOSS SEK  20 MILLION VERSUS LOSS SEK 14.8
MILLION
YEAR AGO

Source text for Eikon:  ID:nWkrG6vTk 
Further company coverage:  NVP.ST 

 (Gdynia Newsroom)
 ((gdynia.newsroom@thomsonreuters.com; +48 58 772 0920;))